- Published: 19 August 2015
SPRINGFIELD – Thanks to new screening methods such as tomosynthesis, breast cancer occurrences have been steadily decreasing since the early 2000’s. A new law sponsored by Senator John Mulroe (D-CHICAGO) adding the screening method to the list of covered low-dose screenings was signed today by the governor.
“This is a medically proven screening method that increases detection rates and because of its sensitivity, helps reduce unnecessary call backs during an already stressful time,” Mulroe said. “It is a good practice to keep the medical industry moving forward when the technology is available.”
Previous technologies only took a single dimension view of breast tissue when screening for cancerous cells. Tomosynthesis, also known as a 3D mammogram, takes a multidimensional view of the breast during the screening. As a result, a 3D mammogram has a higher success rate of detecting cancerous cells that are often difficult to detect, due to either size or dense breast tissue.
Senate Bill 54 amends the insurance code by adding tomosynthesis to the list of definitions of low-dose mammograms. As a result, the insurance mandate will cover 3D mammograms as well as the traditional 2D mammograms.
“This law will not only help save lives of at-risk women who may not have known about this technology or may not have been previously covered, but also save them from additional stress and discomfort,” Mulroe said. “It is our duty to protect the health and well-being of people in this state, and if we can save them time, money and emotional hardship then that is a bonus.”
The law becomes effective July 1, 2016.